JSF Financial, LLC

Position in EXEL — Exelixis, Inc.

CIK 1802224 LOS ANGELES, CA

Position in EXEL

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,354,156

New position

Shares Held

24,888

first reported quarter

Ownership

0.010%

of shares outstanding

% of Portfolio

0.76%

of 13F equity value

Holder Rank

#309

of 754 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JSF Financial, LLC holds $1,412,512 across 3 Biotechnology names. EXEL ranks #1 (95.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	24,888	$1,354,156
2	ALXO	Alx Oncology Holdings Inc	17,500	$36,225
3	ALLO	Allogene Therapeutics, Inc.	10,640	$22,131

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,354,156	24,888	—	Shares	Sole	2026-07-28
No filing history on record for this holder in this stock.